Melanoma: Public consultation instructions
Information on public consultation
Feedback on the draft content will be considered by Melanoma Guidelines Working Party members.
How to submit comments
Step 1: Create a user account
Before you comment, we recommend you create a user account by completing the simple registration form. Once you complete the user registration form, you will automatically be logged in and directed back to this content page.
By having a user account on our website, your comments can be attributed to you and you also receive alerts updating you on any replies to your comments.
If you wish you can skip this step and choose to comment anonymously. However, this means that we won't be able to notify you to let you know how the Working Party addressed your comment.
Browse and review the draft Melanoma guidelines content.
When you are in the relevant section, click the blue button to expand the comment field and follow the prompts to provide your feedback on that section. You can attach citations as part of your comment. The wiki does not accept PDF or Word document attachments. If you wish to provide this type of document, please email it to: guidelines(at)cancer.org.au
If you have general feedback about the guidelines, please submit your comment using the button below:
General information on how to comment
- If you have identified any gaps or errors in the content please suggest suitable text for inclusion.
- Statements regarding the inclusion/exclusion of issues should be clearly supported by scientific evidence.
- People unable to create a wiki account and comment using the 'make a comment' function may email feedback to guidelines(at)cancer.org.au within the specified timeframe of public consultation.
Comments on language, terminology, etc.
- If you have comments on the language and/or terminology of the content, please provide suggested replacement text.
- The Melanoma Guidelines Working Party would also appreciate suggestions for future research.
How we respond to comments and what we won't accept
How we respond to comments:
- All comments will be screened by the Clinical Guidelines Network, Cancer Council Australia, and any inappropriate comments can be removed. Minor changes (e.g. correcting a typographical error) may be made on your behalf.
- At the end of the consultation period, all relevant comments will be reviewed by the Melanoma Guidelines Working Party.
- Cancer Council Australia reserves the right to summarise and edit comments received during consultation, or not to publish them at all, where in reasonable opinion of Cancer Council Australia, the comments are voluminous, publication would be unlawful or publication would be otherwise inappropriate.
- Relevant comments and the Working Party’s response may be published on this wiki with the finalised guidelines.
We are unable to accept:
- Comments that are not made using the wiki ‘Make a comment’ function, or guidelines(at)cancer.org.au
- Comments made after the public consultation period closes.
- Confidential information or personal medical information about yourself or another person from which your or the other person’s identity could be ascertained.
How we respond to additional/new evidence suggestions
- All comments will be screened by a Project Officer who is responsible for literature searches and evidence updates. If the evidence meets the inclusion and exclusion criteria of the associated clinical question, a critical appraisal of the study publication will be forwarded to the authors for further review. Where appropriate, modifications will be made to the guidelines.
Problems submitting a comment?
If you have difficulties using the ‘Make a comment’ function please contact the Project Manager, Clinical Guidelines Network, Cancer Council Australia at guidelines(at)cancer.org.au
These guidelines are going to be updated regularly and it is possible to submit comments on an ongoing basis. Authors are going to process and review comments as they will come in. See Clinical Practice Guideline Development Handbook on the procedures around literature updates and processing of comments after a guideline has been launched.